CG Oncology (CGON) stock: insider trades, news & valuation
Net buyingShare price and insider trades
CG Oncology insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $24.8M and 2 sold $5.1M of CGON stock on the open market.
Get emailed when insiders cluster-buy stocks like CGON
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
CGON insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $2.0M | 4 |
| Q2 2026 | $24.8M | 1 | $2.0M | 6 |
| Q1 2026 | — | 0 | $710K | 4 |
| Q4 2025 | — | 0 | $344K | 3 |
| Q3 2025 | — | 0 | $200K | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 CG Oncology, Inc. insider reported open-market purchases totaling $24.8M, while 2 insiders reported sales totaling $5.1M. 18 of 18 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 17SEC | Leonard E PostDirector | Sell Plan | 1,000 | $72.98 | $73K | -12.6% | — |
| Aug 18SEC | Leonard E PostDirector | Sell Plan | 1,000 | $74.54 | $75K | -14.4% | — |
| Jul 17SEC | Leonard E PostDirector | Sell Plan | 1,000 | $71.17 | $71K | -10.3% | — |
| Jul 14SEC | James MulayDirector | Sell Plan | 24,165 | $75.16 | $1.8M | -15.1% | — |
| Jun 29SEC | Brian Guan-chyun LiuDirector | Buy | 371,0851,886,236 held (+24%) | $66.87 | $24.8M | -4.6% | — |
| Jun 25SEC | Leonard E PostDirector | Sell Plan | 5,000 | $70.00 | $350K | -8.8% | — |
| Jun 23SEC | Leonard E PostDirector | Sell Plan | 5,000 | $65.00 | $325K | -1.8% | — |
| Jun 16SEC | James MulayDirector | Sell Plan | 1,310 | $60.12 | $79K | +6.2% | — |
| Jun 16SEC | James MulayDirector | Sell Plan | 654 | $60.12 | $39K | +6.2% | — |
| Jun 5SEC | Leonard E PostDirector | Sell Plan | 1,000 | $54.50 | $54K | +17.1% | — |
| Apr 20SEC | James MulayDirector | Sell Plan | 15,600 | $73.01 | $1.1M | -12.6% | — |
| Mar 17SEC | James MulayDirector | Sell Plan | 1,310 | $63.50 | $83K | +0.5% | — |
| Mar 17SEC | James MulayDirector | Sell Plan | 654 | $63.50 | $42K | +0.5% | — |
| Jan 13SEC | James MulayDirector | Sell Plan | 10,491 | $52.99 | $556K | +20.4% | — |
| Jan 13SEC | James MulayDirector | Sell Plan | 654 | $44.16 | $29K | +44.5% | — |
| Nov 18SEC | Leonard E PostDirector | Sell Plan | 1,000 | $41.43 | $41K | +54.0% | — |
| Oct 15SEC | Leonard E PostDirector | Sell Plan | 1,000 | $43.25 | $43K | +47.6% | — |
| Oct 10SEC | James MulayDirector | Sell Plan | 5,903 | $43.99 | $260K | +45.1% | — |
| Oct 1SEC | Leonard E PostDirector | Sell Plan | 5,000 | $40.09 | $200K | +59.2% | — |
Insiders at CG Oncology, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Brian Guan-chyun LiuDirector | $24.8M | — | Jun 29, 2026 | — |
| James MulayDirector | — | $4.0M | Jul 14, 2026 | — |
| Leonard E PostDirector | — | $1.2M | Sep 17, 2026 | — |
CGON stock: common questions
Are CG Oncology, Inc. insiders buying CGON stock?
In the past 12 months, 1 insiders reported open-market purchases of CGON worth $24.8M. The latest was Director Brian Guan-chyun Liu bought $24.8M of CGON at $66.87 — first open-market purchase in our records; raises the stake by 24%.
Are CG Oncology, Inc. insiders selling CGON stock?
2 insiders reported sales worth $5.1M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CGON's 52-week range?
Over the past year CGON has traded between $37.37 and $80.68. It last closed at $63.82 on Oct 9, 2026.